The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1303
January 12, 2009
View Complete Issue         Table of Contents 2019 
Issue 1303
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Long-Acting Beta-2 Agonists in Asthma
January 12, 2009 (Issue: 1303)
Continued use of a long-acting beta-2 agonist for treatment of asthma may cause down-regulation of the beta-2 receptor with loss of the bronchoprotective effect from rescue therapy with a short-acting beta-2 agonist. After a large study (SMART) found...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1303
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.